|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.45/-0.64
|
企業價值
18.96M
|
資產負債 |
每股賬面淨值
0.75
|
現金流量 |
現金流量率
--
|
損益表 |
收益
651.00K
|
每股收益
0.83
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/09/21 03:38 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. |